[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fkXvuQj4ow0qJ5U_k6g7LtRvA_2DX9flIa60ZIOefIxI":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":43,"rows":50},"Centre Hospitalier Régional Metz-Thionville",[4],117,false,18,1,4311630,3,112,[14,17,19,22,24,26,28,30],{"name":15,"count":16},"Cataract",7,{"name":18,"count":11},"Keratoconus",{"name":20,"count":21},"Pain",2,{"name":23,"count":21},"Fuchs' Endothelial Corneal Dystrophy",{"name":25,"count":21},"Pseudophakic Bullous Keratopathy",{"name":27,"count":21},"Covid19",{"name":29,"count":21},"Cardiac Arrest",{"name":31,"count":21},"Burns",[33,38],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT06469970","Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults","2027-03-28","Glucose 30% Intravenous Solution",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT04985695","Influence of Analgesic Technique on Post Operative Rehabilitation After Median Laparotomy","2028-10-10","Epidural analgesia",[44,45,46,47,48,49],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[51,75,98,116,143,169],{"intervention":37,"totalTrials":9,"cells":52},{"EARLY_PHASE1":53,"PHASE1":56,"PHASE2":58,"PHASE3":69,"PHASE4":71,"NA":73},{"trials":54,"activeCount":55},[],0,{"trials":57,"activeCount":55},[],{"trials":59,"activeCount":9,"soonestReadout":36},[60],{"nctId":34,"briefTitle":35,"status":61,"phases":62,"primaryCompletion":36,"completion":36,"start":63,"enrollment":64,"conditions":65,"interventions":68},"RECRUITING",[46],"2024-11-28",15,[31,66,67],"Intensive Care","Emergencies",[37],{"trials":70,"activeCount":55},[],{"trials":72,"activeCount":55},[],{"trials":74,"activeCount":55},[],{"intervention":42,"totalTrials":9,"cells":76},{"EARLY_PHASE1":77,"PHASE1":79,"PHASE2":81,"PHASE3":83,"PHASE4":85,"NA":87},{"trials":78,"activeCount":55},[],{"trials":80,"activeCount":55},[],{"trials":82,"activeCount":55},[],{"trials":84,"activeCount":55},[],{"trials":86,"activeCount":55},[],{"trials":88,"activeCount":9,"soonestReadout":41},[89],{"nctId":39,"briefTitle":40,"status":61,"phases":90,"primaryCompletion":41,"completion":91,"start":92,"enrollment":93,"conditions":94,"interventions":96},[49],"2029-04-10","2021-10-11",110,[95],"Laparotomy",[42,97],"Bilateral rectus sheath block",{"intervention":97,"totalTrials":9,"cells":99},{"EARLY_PHASE1":100,"PHASE1":102,"PHASE2":104,"PHASE3":106,"PHASE4":108,"NA":110},{"trials":101,"activeCount":55},[],{"trials":103,"activeCount":55},[],{"trials":105,"activeCount":55},[],{"trials":107,"activeCount":55},[],{"trials":109,"activeCount":55},[],{"trials":111,"activeCount":9,"soonestReadout":41},[112],{"nctId":39,"briefTitle":40,"status":61,"phases":113,"primaryCompletion":41,"completion":91,"start":92,"enrollment":93,"conditions":114,"interventions":115},[49],[95],[42,97],{"intervention":117,"totalTrials":9,"cells":118},"Nasal provocation test - 725 Dermatophagoides Pteronyssinus",{"EARLY_PHASE1":119,"PHASE1":121,"PHASE2":123,"PHASE3":125,"PHASE4":127,"NA":141},{"trials":120,"activeCount":55},[],{"trials":122,"activeCount":55},[],{"trials":124,"activeCount":55},[],{"trials":126,"activeCount":55},[],{"trials":128,"activeCount":55},[129],{"nctId":130,"briefTitle":131,"status":132,"phases":133,"primaryCompletion":134,"completion":134,"start":135,"enrollment":136,"conditions":137,"interventions":140},"NCT04915352","Interest of Nasal Provocation Tests for Diagnosis of House Mites Allergic Rhinitis","TERMINATED",[48],"2024-07-05","2022-03-07",8,[138,139],"Mite Allergy","Respiratory Disease",[117],{"trials":142,"activeCount":55},[],{"intervention":144,"totalTrials":9,"cells":145},"Contrast agent: SonoVue®.",{"EARLY_PHASE1":146,"PHASE1":148,"PHASE2":150,"PHASE3":152,"PHASE4":165,"NA":167},{"trials":147,"activeCount":55},[],{"trials":149,"activeCount":55},[],{"trials":151,"activeCount":55},[],{"trials":153,"activeCount":55},[154],{"nctId":155,"briefTitle":156,"status":157,"phases":158,"primaryCompletion":159,"completion":159,"start":160,"enrollment":161,"conditions":162,"interventions":164},"NCT02884297","HexafluOride, a Contrast Agent for Placenta Echo-angiography","COMPLETED",[47],"2019-09-30","2016-10-12",55,[163],"Pregnancy",[144],{"trials":166,"activeCount":55},[],{"trials":168,"activeCount":55},[],{"intervention":170,"totalTrials":9,"cells":171},"saline solution",{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":182},{"trials":173,"activeCount":55},[],{"trials":175,"activeCount":55},[],{"trials":177,"activeCount":55},[],{"trials":179,"activeCount":55},[],{"trials":181,"activeCount":55},[],{"trials":183,"activeCount":55},[184],{"nctId":185,"briefTitle":186,"status":157,"phases":187,"primaryCompletion":188,"completion":188,"start":189,"enrollment":190,"conditions":191,"interventions":193},"NCT02279121","ATAPAC Study (TauroLock Activity in Adult Cancer Patients)",[49],"2016-03","2014-11",162,[192],"Catheter-Related Infections",[170]]